Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors. / Thiele, Stefanie; Malmgaard-Clausen, Mikkel; Engel-Andreasen, Jens; Steen, Anne; Rummel, Pia C; Nielsen, Mads C; Gloriam, David E.; Frimurer, Thomas Michael; Ulven, Trond; Rosenkilde, Mette.
I: Journal of Medicinal Chemistry, Bind 55, Nr. 18, 27.09.2012, s. 8164-77.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors
AU - Thiele, Stefanie
AU - Malmgaard-Clausen, Mikkel
AU - Engel-Andreasen, Jens
AU - Steen, Anne
AU - Rummel, Pia C
AU - Nielsen, Mads C
AU - Gloriam, David E.
AU - Frimurer, Thomas Michael
AU - Ulven, Trond
AU - Rosenkilde, Mette
PY - 2012/9/27
Y1 - 2012/9/27
N2 - Among 18 human chemokine receptors, CCR1, CCR4, CCR5, and CCR8 were activated by metal ion Zn(II) or Cu(II) in complex with 2,2'-bipyridine or 1,10-phenanthroline with similar potencies (EC(50) from 3.9 to 172 μM). Besides being agonists, they acted as selective allosteric enhancers of CCL3. These actions were dependent on a conserved glutamic acid at TM-7 (VII:06/7.39). A screening of 20 chelator analogues in complex with Zn(II) identified compounds with increased potencies, with 7 reaching highest potency at CCR1 (EC(50) of 0.85 μM), 20 at CCR8 (0.39 μM), and 8 at CCR5 (1.0 μM). Altered selectivity for CCR1 and CCR8 over CCR5 (11, 12) and a receptor-dependent separation of allosteric from intrinsic properties were achieved (20). The pocket similarities of CCR1 and CCR8, contrary to CCR5 as proposed by the ligand screen, were elaborated by computational modeling. These studies facilitate exploration of chemokine receptors as possible targets for therapeutic intervention.
AB - Among 18 human chemokine receptors, CCR1, CCR4, CCR5, and CCR8 were activated by metal ion Zn(II) or Cu(II) in complex with 2,2'-bipyridine or 1,10-phenanthroline with similar potencies (EC(50) from 3.9 to 172 μM). Besides being agonists, they acted as selective allosteric enhancers of CCL3. These actions were dependent on a conserved glutamic acid at TM-7 (VII:06/7.39). A screening of 20 chelator analogues in complex with Zn(II) identified compounds with increased potencies, with 7 reaching highest potency at CCR1 (EC(50) of 0.85 μM), 20 at CCR8 (0.39 μM), and 8 at CCR5 (1.0 μM). Altered selectivity for CCR1 and CCR8 over CCR5 (11, 12) and a receptor-dependent separation of allosteric from intrinsic properties were achieved (20). The pocket similarities of CCR1 and CCR8, contrary to CCR5 as proposed by the ligand screen, were elaborated by computational modeling. These studies facilitate exploration of chemokine receptors as possible targets for therapeutic intervention.
KW - Allosteric Regulation
KW - Animals
KW - Binding Sites
KW - COS Cells
KW - Cercopithecus aethiops
KW - Chelating Agents
KW - Copper
KW - Glutamic Acid
KW - Humans
KW - Ligands
KW - Models, Molecular
KW - Organometallic Compounds
KW - Protein Structure, Tertiary
KW - Pyridines
KW - Receptors, CCR
KW - Substrate Specificity
KW - Zinc
U2 - 10.1021/jm301121j
DO - 10.1021/jm301121j
M3 - Journal article
C2 - 22957890
VL - 55
SP - 8164
EP - 8177
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
SN - 0022-2623
IS - 18
ER -
ID: 45811325